GlaxoSmithKline Intellectual Property Development Limited
发明人:
ANDERSON, Niall Andrew,CAMPBELL-CRAWFORD, Matthew Howard James,HANCOCK, Ashley Paul,PRITCHARD, John Martin,REDMOND, Joanna Mary
申请号：
ES15767475
公开号：
ES2690748T3
申请日:
2015.09.22
申请国别(地区):
ES
年份:
2018
代理人:
摘要：
A compound of formula (I): ** Formula ** which is 4- (3-fluoro-3- (2- (5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl) ethyl acid ) pyrrolidin-1-yl) -3- (3- (2-methoxyethoxy) phenyl) butanoic acid, or a pharmaceutically acceptable salt thereof.Un compuesto de fórmula (I): **Fórmula** que es ácido 4-(3-fluoro-3-(2-(5,6,7,8-tetrahidro-1,8-naftiridin-2-il)etil)pirrolidin-1-il)-3-(3-(2-metoxietoxi)fenil)butanoico, o una sal farmacéuticamente aceptable del mismo.
